Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Sabbatini · SciRah

Researcher profile · Semantic Scholar

P. Sabbatini

Share profile

P. Sabbatini — researcher profile on SciRah

h-index: 59
Works: 248
Citations: 19K

Most-cited papers

Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients
A. Zehir, R. Benayed, Ronak H. Shah, Aijazuddin Syed +96 more
2017Nature Medicine3,034 citations Open access
Semantic Scholar
OncoKB: A Precision Oncology Knowledge Base
D. Chakravarty, Jian-Jiong Gao, Sarah M. Phillips, R. Kundra +44 more
2017JCO Precision Oncology2,423 citations Open access
Semantic Scholar
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.
E. Basch, A. Deal, M. Kris, H. Scher +14 more
2016Journal of Clinical Oncology2,156 citations Open access
Semantic Scholar
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
R. Coleman, M. Brady, T. Herzog, P. Sabbatini +15 more
2017The Lancet Oncology548 citations Open access
Semantic Scholar
Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
S. Suehnholz, Moriah H. Nissan, Hong-Xin Zhang, R. Kundra +22 more
2023Cancer Discovery302 citations Open access
Semantic Scholar
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
R. Coleman, N. Spirtos, Danielle M. Enserro, T. Herzog +20 more
2019New England Journal of Medicine282 citations Open access
Semantic Scholar
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
D. Armstrong, R. Alvarez, J. Bakkum-Gamez, L. Barroilhet +28 more
2019The Journal of the National Comprehensive Cancer Network248 citations Open access
Semantic Scholar
Ovarian cancer, version 1.2016: Clinical practice guidelines in oncology
R. Morgan, D. Armstrong, R. Alvarez, J. Bakkum-Gamez +28 more
2016223 citations Open access
Semantic Scholar
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
R. Morgan, D. Armstrong, R. Alvarez, J. Bakkum-Gamez +28 more
2016The Journal of the National Comprehensive Cancer Network155 citations
Semantic Scholar
OncoTree: A Cancer Classification System for Precision Oncology.
R. Kundra, Hong-Xin Zhang, R. Sheridan, S. Sirintrapun +62 more
2021JCO Clinical Cancer Informatics143 citations Open access
Semantic Scholar
Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials
D. Hyman, D. Solit, M. Arcila, D. Cheng +4 more
2015Drug Discovery Today141 citations Open access
Semantic Scholar
Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.
P. Sabbatini, P. Harter, G. Scambia, J. Sehouli +25 more
2013Journal of Clinical Oncology138 citations Open access
Semantic Scholar
Ovarian cancer, version 2.2013: Featured updates to the NCCN guidelines
R. Morgan, R. Alvarez, D. Armstrong, R. Burger +22 more
2013135 citations Open access
Semantic Scholar
A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
S. Kaye, L. Fehrenbacher, R. Holloway, A. Amit +7 more
2012Clinical Cancer Research120 citations Open access
Semantic Scholar
CLINICAL UTILITY OF PROSPECTIVE MOLECULAR CHARACTERIZATION IN ADVANCED ENDOMETRIAL CANCER
Tara E. Soumerai, M. Donoghue, C. Bandlamudi, P. Srinivasan +33 more
2018Clinical Cancer Research113 citations Open access
Semantic Scholar
A Phase 1b Dose Escalation Study of Ipafricept (OMP-54F28) in Combination with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
K. Moore, Camille C. Gunderson, P. Sabbatini, D. Mcmeekin +8 more
2019Gynecologic Oncology95 citations Open access
Semantic Scholar
Ovarian cancer, version 2.2013.
R. Morgan, R. Alvarez, D. Armstrong, R. Burger +22 more
2013The Journal of the National Comprehensive Cancer Network81 citations
Semantic Scholar
Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial
Takemasa Tsuji, P. Sabbatini, A. Jungbluth, Erika Ritter +6 more
2013Cancer immunology research65 citations Open access
Semantic Scholar
Phase II Study of LY3023414 in Patients with Advanced Endometrial Cancer Harboring Activating Mutations in the PI3K Pathway
Maria M. Rubinstein, D. Hyman, Imogen Caird, H. Won +15 more
2019Cancer59 citations Open access
Semantic Scholar
A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study.
R. Coleman, Danielle M. Enserro, N. Spirtos, T. Herzog +10 more
201857 citations
Semantic Scholar
Corrigendum: Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes
A. Zehir, R. Benayed, Ronak H. Shah, Aijazuddin Syed +96 more
2017Nature Medicine56 citations Open access
Semantic Scholar
A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
R. O'Cearbhaill, G. Ragupathi, Jianglong Zhu, Qian Wan +9 more
2016Cancers48 citations Open access
Semantic Scholar
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
J. Barlin, F. Dao, N. Zgheib, S. Ferguson +7 more
2012Gynecologic Oncology46 citations
Semantic Scholar
A phase III randomized controlled clinical trial of carboplatin and paclitaxel alone or in combination with bevacizumab followed by bevacizumab and secondary cytoreductive surgery in platinum-sensitive, recurrent ovarian, peritoneal primary and fallopian tube cancer (Gynecologic Oncology Group 0213)
R. Coleman, M. Brady, T. Herzog, P. Sabbatini +6 more
201545 citations
Semantic Scholar
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
Julia L. Boland, Qin C. Zhou, Madhuri Martin, M. Callahan +15 more
2018Gynecologic Oncology44 citations Open access
Semantic Scholar
Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment.
E. Basch, A. Deal, A. Dueck, A. Bennett +9 more
201740 citations
Semantic Scholar
A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.
R. O'Cearbhaill, W. Deng, Lee-may Chen, J. Lucci +11 more
2019Gynecologic Oncology25 citations Open access
Semantic Scholar
Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer.
A. Green, Sara M. Tabatabai, C. Aghajanian, O. Landgren +6 more
2022JAMA Oncology23 citations Open access
Semantic Scholar
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission
B. Manning-Geist, S. Gnjatic, C. Aghajanian, J. Konner +13 more
2023Cancers19 citations Open access
Semantic Scholar
Pathogenic germline variants in non-BRCA homologous recombination genes in ovarian cancer: analysis of tumor phenotype and survival
R. Kahn, P. Selenica, Thomas Boerner, K. Roche +24 more
2023Gynecologic Oncology17 citations Open access
Semantic Scholar
A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC).
R. O'Cearbhaill, A. Wolfer, P. DiSilvestro, David M. O'Malley +15 more
2018Annals of Oncology15 citations Open access
Semantic Scholar
Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC).
R. O'Cearbhaill, D. Mcmeekin, G. Mantia-Smaldone, C. Gunderson +9 more
201614 citations
Semantic Scholar
Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis
S. Gordhandas, B. Schlappe, Qin C. Zhou, A. Iasonos +9 more
2022Gynecologic Oncology Reports12 citations Open access
Semantic Scholar
OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer.
D. Chakravarty, Sarah M. Phillips, Jian-Jiong Gao, R. Kundra +16 more
201611 citations
Semantic Scholar
IMPACT OF PROVIDER VOLUME ON FRONT-LINE CHEMOTHERAPY GUIDELINE COMPLIANCE AND OVERALL SURVIVAL IN ELDERLY PATIENTS WITH ADVANCED OVARIAN CANCER
E. Aviki, J. Lavery, K. Roche, R. Cowan +11 more
2020Gynecologic Oncology10 citations Open access
Semantic Scholar
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer
B. Manning-Geist, S. Gordhandas, D. Giri, A. Iasonos +13 more
2021Gynecologic Oncology9 citations Open access
Semantic Scholar
Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy
Julia L. Boland, Qin C. Zhou, A. Iasonos, R. O'Cearbhaill +7 more
2020Gynecologic Oncology9 citations Open access
Semantic Scholar
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation
A. Green, Sara M. Tabatabai, Xing Bai, Akriti Mishra Meza +12 more
2022JAMA Network Open8 citations Open access
Semantic Scholar
Bevacizumab after bevacizumab in platinum-sensitive recurrent ovarian cancer: A subgroup analysis of GOG0213.
R. Coleman, M. Brady, T. Herzog, D. Armstrong +6 more
20168 citations
Semantic Scholar
Engaging community-based cancer physicians: experience of the Memorial Sloan Kettering Cancer Center Cancer Alliance
Allison Lipitz-Snyderman, Jessica Kennington, B. Hogan, D. Korenstein +5 more
2019The Journal of the National Comprehensive Cancer Network7 citations Open access
Semantic Scholar
A phase II, single arm study of iniparib in patients with BRCA1 or BRCA2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
K. Bell-McGuinn, J. Konner, W. Tew, M. Hensley +5 more
2015International Journal of Gynecologic Cancer7 citations Open access
Semantic Scholar
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study
N. Korde, E. Tavitian, Donna Mastey, Joseph Lengfellner +23 more
2023EClinicalMedicine6 citations Open access
Semantic Scholar
LONG-TERM OUTCOMES OF PATIENTS WITH RECURRENT OVARIAN CANCER TREATED WITH A POLYVALENT VACCINE WITH BEVACIZUMAB COMBINATION
R. Kahn, G. Ragupathi, Qin C. Zhou, A. Iasonos +8 more
2022Cancer Immunology and Immunotherapy6 citations Open access
Semantic Scholar
Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
C. Kyi, E. Doubrovina, Qin C. Zhou, S. Kravetz +6 more
2021Journal for ImmunoTherapy of Cancer6 citations Open access
Semantic Scholar
A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC): Genomic sequencing and updated efficacy results
R. O'Cearbhaill, K. Homicsko, A. Wolfer, P. DiSilvestro +11 more
2020Gynecologic Oncology6 citations
Semantic Scholar
A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission.
R. O'Cearbhaill, S. Gnjatic, C. Aghajanian, A. Iasonos +8 more
20186 citations
Semantic Scholar
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
P. Johannet, M. Flint, M. Chui, J. Konner +15 more
2025Gynecologic Oncology5 citations Open access
Semantic Scholar
A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer
K. Lavigne, D. Hyman, Qin C. Zhou, A. Iasonos +11 more
2018International Journal of Gynecologic Cancer5 citations Open access
Semantic Scholar
Effect of metformin on recurrence-free survival and overall survival in diabetic patients affected by advanced ovarian cancer.
C. Simonelli, M. Bertolotti, P. Sabbatini, J. Berek +6 more
20135 citations
Semantic Scholar
Digitalizing the Clinical Research Informed Consent Process: Assessing the Participant Experience in Comparison With Traditional Paper-Based Methods
Michael T. Buckley, Mary-Ellen O'Shea, Sangeeta Kundu, A. Lipitz-Snyderman +7 more
2022JCO Oncology Practice4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. O'Cearbhaill×20
Invite
R. O'Cearbhaill — researcher profile on SciRah
C. Aghajanian×19
Invite
C. Aghajanian — researcher profile on SciRah
A. Iasonos×13
Invite
A. Iasonos — researcher profile on SciRah
D. Armstrong×10
Invite
D. Armstrong — researcher profile on SciRah

×10

Invite

J. Konner — researcher profile on SciRah

Invite

D. Hyman — researcher profile on SciRah

Invite

D. O'Malley — researcher profile on SciRah

Invite

W. Tew — researcher profile on SciRah

Invite

D. Solit — researcher profile on SciRah

Invite

M. Hensley — researcher profile on SciRah

Invite

R. Kundra — researcher profile on SciRah

Invite

N. Schultz — researcher profile on SciRah